Cataract Surgery in India
Get Cataract Surgery at internationally accredited (JCI/NABH) Indian hospitals at a fraction of Western costs, with end-to-end international patient support — visa, travel, stay, and follow-up care.
Approximate cost range: $800 – $3,500
Cataract Surgery in UAE
Cataract Surgery at leading UAE hospitals in Dubai and Abu Dhabi — world-class care closer to home, visa-free entry for many nationalities, international specialists, and modern facilities.
Overview
Cataract surgery is one of the most commonly performed and highly successful ophthalmic procedures in the world, achieving visual rehabilitation in over 95% of patients when performed by experienced surgeons using modern phacoemulsification or femtosecond laser-assisted techniques. International patients choose India and the UAE through GAF Healthcare for access to JCI- and NABH/DHA-accredited eye hospitals, sub-speciality-trained vitreoretinal and anterior segment surgeons, and a full spectrum of premium intraocular lens (IOL) technologies—at costs that are a fraction of what the same standard of care commands in Europe, North America, or Australia. GAF Healthcare coordinates every step of the medical journey, from pre-operative biometry review and surgical planning to post-operative follow-up, ensuring seamless, transparent, and clinically rigorous care for every patient.
Hospital Stay: 0–1 days (day-care / ambulatory procedure; overnight admission is rare and typically reserved for patients with complex comorbidities such as advanced glaucoma, dense posterior polar cataracts, or uncontrolled systemic disease) • Total Stay in Country (Fit-to-Fly): 1–2 weeks (most patients are cleared for short-haul flights within 7 days and long-haul international flights within 10–14 days, subject to final slit-lamp and IOP review by the operating surgeon; bilateral sequential surgery may extend this window by 5–7 days) • Success Rate: 95–98% (visual acuity improvement to 20/40 or better in the operated eye, in the absence of pre-existing macular or optic nerve pathology)
What Is It?
The crystalline lens of the human eye is a biconvex, avascular structure suspended behind the iris by the zonular fibres of the ciliary body. Its transparency depends on the highly ordered arrangement of lens crystallin proteins. Cataract—defined as any opacity of the crystalline lens that reduces visual acuity, contrast sensitivity, or quality of life—develops when oxidative stress, ultraviolet radiation, metabolic dysregulation (most commonly hyperglycaemia in diabetes mellitus), corticosteroid exposure, trauma, or age-related protein aggregation disrupt this molecular architecture. The result is progressive scattering and absorption of incoming light, producing symptoms that range from mild glare and monocular diplopia in early nuclear or posterior subcapsular cataracts to near-total visual loss in hypermature (Morgagnian) cataracts. Physiologically, advanced cataract also elevates the risk of secondary angle-closure glaucoma due to lens intumescence, making timely surgical intervention both visually and structurally protective.
The global standard of care is surgical extraction of the opacified lens and replacement with an artificial intraocular lens (IOL). Phacoemulsification—ultrasonic emulsification of the lens nucleus through a 2.2–2.8 mm clear corneal incision—has supplanted extracapsular cataract extraction (ECCE) as the dominant technique in high-volume, technology-equipped centres. Femtosecond laser-assisted cataract surgery (FLACS) adds an additional layer of precision by using a 1030 nm infrared laser to perform the anterior capsulorhexis, lens fragmentation, and corneal incisions with micron-level reproducibility, reducing ultrasound energy delivered to the corneal endothelium and improving IOL centration. The introduction of advanced-technology IOLs—including toric lenses for astigmatism correction, extended depth-of-focus (EDOF) lenses, and trifocal diffractive IOLs—has transformed cataract surgery from a procedure that merely restores functional vision to one that can achieve spectacle independence across a full range of distances.
In India and the UAE, leading accredited eye hospitals perform tens of thousands of phacoemulsification procedures annually, many with subspecialty fellowship-trained anterior segment surgeons who have published peer-reviewed research and trained at institutions such as Moorfields Eye Hospital (London), LV Prasad Eye Institute (Hyderabad), or Wills Eye Hospital (Philadelphia). This combination of surgical volume, technology infrastructure, and internationally benchmarked training is the clinical foundation that makes both destinations medically credible choices for international patients seeking cataract surgery.
Candidates
• ELIGIBLE PATIENTS:
• Adults with age-related (senile) nuclear, cortical, or posterior subcapsular cataract causing best-corrected visual acuity (BCVA) of 20/50 or worse, or significant glare disability even at higher Snellen acuities
• Patients with visually significant cataract secondary to diabetes mellitus, prolonged corticosteroid use (topical, inhaled, or systemic), uveitis, or trauma
• Patients with phacomorphic glaucoma (lens-induced angle closure) regardless of visual acuity—surgery is urgent in this subgroup
• Paediatric patients with congenital or developmental cataracts (managed at specialised paediatric ophthalmology units with general anaesthesia and amblyopia management protocols)
• Patients seeking refractive lens exchange (RLE) for high myopia or hyperopia with incipient lenticular changes who wish to achieve spectacle independence
• Patients with concurrent pathology (e.g., epiretinal membrane, mild AMD) where cataract is the primary treatable cause of vision loss
• REQUIRED PRE-OPERATIVE DIAGNOSTICS:
• Uncorrected and best-corrected visual acuity (Snellen / LogMAR)
• Slit-lamp biomicroscopy with grading of cataract type and density (LOCS III grading system)
• Optical biometry (IOLMaster 700 or Lenstar LS 900) for axial length, anterior chamber depth, keratometry, and white-to-white measurements—essential for IOL power calculation using modern formulae (Barrett Universal II, Hill-RBF, Kane formula)
• Corneal topography and tomography (Pentacam / Scheimpflug imaging)—mandatory for toric IOL planning and to rule out subclinical keratoconus
• Specular microscopy for endothelial cell density (ECD)—critical in patients with Fuchs endothelial dystrophy or prior intraocular surgery; ECD below 1,000 cells/mm² significantly increases surgical risk
• Dilated fundus examination (indirect ophthalmoscopy and/or OCT macula/optic nerve)—to identify co-existing pathology that may limit post-operative visual gain
• Intraocular pressure (IOP) measurement (Goldmann applanation tonometry)
• Systemic pre-operative assessment: fasting blood glucose and HbA1c (diabetic patients), blood pressure, and basic coagulation profile in patients on anticoagulants
• A-scan ultrasound biometry if optical biometry is not feasible (e.g., dense cataract precluding laser passage)
• RELATIVE CONTRAINDICATIONS / ELEVATED-RISK CONDITIONS:
• Uncontrolled diabetes (HbA1c > 9%)—increases risk of post-operative infection, poor healing, and cystoid macular oedema (CMO)
• Active intraocular inflammation (uveitis)—surgery should be deferred until the eye is quiet for a minimum of 3 months
• End-stage corneal endothelial disease (ECD < 800 cells/mm²) without concurrent Descemet membrane endothelial keratoplasty (DMEK) planning
• Zonular instability (Marfan syndrome, pseudoexfoliation, prior trauma)—requires capsular tension ring (CTR) or Cionni ring insertion; specialist referral essential
• Active ocular surface disease (severe dry eye, blepharitis) that could compromise accurate biometry or increase infection risk—must be optimised pre-operatively
• Patients with significant macular degeneration or optic atrophy where realistic post-operative expectations must be clearly counselled
Procedure
STANDARD PHACOEMULSIFICATION (PHACO):
The current global gold standard. A 2.2–2.8 mm self-sealing clear corneal incision (CCI) is constructed at the limbus. A continuous curvilinear capsulorhexis (CCC) of 5.0–5.5 mm diameter is created using a bent 26-gauge needle or Utrata forceps. Hydrodissection and hydrodelineation free the lens nucleus, which is then emulsified using torsional or longitudinal ultrasound energy delivered via a phacoemulsification tip (e.g., Alcon Centurion Vision System, Johnson & Johnson Whitestar Signature Pro, Bausch + Lomb Stellaris Elite). Cortical aspiration is performed with an irrigation-aspiration (I/A) handpiece, followed by IOL implantation into the capsular bag through the same microincision using a single-use injector system. The procedure is performed under topical anaesthesia (proxymetacaine or oxybuprocaine drops) supplemented by intracameral preservative-free lidocaine 1%, eliminating the risks of retrobulbar or peribulbar injections in the majority of patients.
FEMTOSECOND LASER-ASSISTED CATARACT SURGERY (FLACS):
Available at premium centres in both India and the UAE, FLACS uses a docked femtosecond laser platform (Alcon LenSx, Johnson & Johnson Catalys, Ziemer Z8) to perform three key steps with sub-100-micron precision before the patient moves to the phacoemulsification suite: (1) anterior capsulotomy—creating a perfectly circular, reproducible opening superior to even expert manual capsulorhexis in terms of diameter and centration, which is critical for toric and multifocal IOL performance; (2) lens fragmentation—softening and pre-cutting the nucleus into quadrants, reducing the cumulative dissipated energy (CDE) of phacoemulsification and thus protecting the corneal endothelium; (3) corneal incisions—including the main wound and paracentesis, and optional limbal relaxing incisions (LRIs) for astigmatism correction. FLACS carries a premium cost but is the preferred approach for patients receiving premium IOLs, those with compromised endothelial cell counts, and post-LASIK/PRK eyes where IOL calculation is already complex.
INTRAOCULAR LENS (IOL) TECHNOLOGY OPTIONS:
• Monofocal IOLs: Provide excellent distance vision (or near vision if targeted for monovision); require spectacles for the non-targeted focal length. Most cost-effective option. Examples: Alcon SA60AT, Johnson & Johnson ZCB00.
• Toric Monofocal IOLs: Correct pre-existing corneal astigmatism (≥ 0.75–1.0 D). Require precise axis alignment using intraoperative aberrometry (ORA System) or digital overlay guidance (Callisto Eye, VERION Image Guided System). Examples: Alcon AcrySof IQ Toric, Hoya Vivinex Toric.
• Extended Depth-of-Focus (EDOF) IOLs: Provide an elongated focal range covering distance and intermediate vision with fewer dysphotopsias (halos/glare) than diffractive multifocals. Ideal for patients who drive at night or work extensively on screens. Examples: Johnson & Johnson Tecnis Symfony, Alcon Vivity, Hoya Vivinex iSert EDOF.
• Trifocal Diffractive IOLs: Three distinct focal points (distance, intermediate ~80 cm, near ~40 cm) enabling full spectacle independence. Associated with a higher incidence of halos and glare, particularly in the first 3–6 months (neuroadaptation period). Not recommended for patients with pupil abnormalities, irregular astigmatism, or macular pathology. Examples: Alcon PanOptix, Zeiss AT LISA tri, PhysIOL FineVision.
• Light-Adjustable Lens (LAL): A photosensitive silicone IOL (RxSight) whose power is non-invasively adjusted post-operatively using UV light treatment, allowing fine-tuning of refraction after healing. Offers the highest level of refractive precision and is increasingly available at top-tier centres.
MANUAL SMALL-INCISION CATARACT SURGERY (MSICS):
A sutureless manual technique using a scleral tunnel incision (6–7 mm), enabling nuclear expression without phacoemulsification. Inferior in wound architecture and visual recovery speed to phaco but appropriate in very dense cataracts (Grade IV–V nuclear sclerosis) where phaco energy requirements would be excessive. Widely performed in India's high-volume public and mission eye hospitals; less common in UAE private centres.
COMPLEX / SECONDARY PROCEDURES:
• Phacovitrectomy: Combined cataract extraction with pars plana vitrectomy (PPV) for patients with concurrent vitreoretinal pathology (e.g., epiretinal membrane, retinal detachment, diabetic vitreous haemorrhage).
• Secondary IOL implantation: For aphakic patients or those with dislocated IOLs following previous complicated surgery, using scleral-fixated (Yamane technique, Gore-Tex suture flanging) or iris-fixated Artisan/Verisyse lenses.
• Descemet Membrane Endothelial Keratoplasty (DMEK) + Phaco: Triple procedure for patients with Fuchs dystrophy and concurrent visually significant cataract.
Cost of Cataract Surgery: India vs. UAE
The cost of cataract surgery varies significantly based on the IOL technology selected (monofocal vs. trifocal/EDOF), the use of femtosecond laser assistance (FLACS), the accreditation level of the hospital, and the destination country. India offers world-class outcomes at a fraction of Western costs—typically 40–60% less than equivalent care in the UAE or 70–80% less than comparable private care in the UK or USA. The UAE commands a premium reflective of its luxury hospital infrastructure, its role as a convenient hub for patients from the Middle East, Africa, and Eastern Europe, and the operating costs of its JCI- and DHA-accredited institutions. Both destinations offer phacoemulsification with premium IOL options performed by fellowship-trained surgeons in internationally accredited facilities. The ranges below cover monofocal IOL (lower end) through femtosecond laser-assisted surgery with trifocal/EDOF premium IOL (upper end), per eye, inclusive of pre-operative workup at the surgical centre, surgeon fees, hospital/OR fees, IOL, and immediate post-operative medications.
| Destination | Estimated Cost (USD) | Key Advantage |
|---|---|---|
| India | $600 – $2,500 | ~52% less than the UAE |
| UAE (Dubai/Abu Dhabi) | $1,500 – $5,000 | Premium care, JCI/DHA accredited |
Estimates typically include surgery, hospital stay, and standard medications. Contact us for a personalised quote.
Recovery & Aftercare
PHASE 1 — REMOTE PRE-CONSULTATION (Week 1–2 before travel): Patients submit existing ophthalmic records, spectacle prescription, and recent photographs of their fundus or anterior segment to GAF Healthcare's clinical coordination team. A board-certified ophthalmologist at the partner hospital reviews the case and issues a preliminary surgical plan including recommended IOL type, biometry requirements, and estimated total cost. GAF Healthcare's team assists with e-Medical visa applications for India (typically processed in 3–5 business days) or UAE entry documentation.
PHASE 2 — ARRIVAL & PRE-OPERATIVE WORKUP (Day 1–2): The patient arrives at the destination city. GAF Healthcare provides airport pick-up and transfer to the accredited hospital or hotel. On Day 1, a comprehensive pre-operative ophthalmic examination is conducted: BCVA, slit-lamp, dilated fundus exam, IOLMaster optical biometry, Pentacam tomography, specular microscopy, and IOP measurement. Systemic clearance (blood glucose, HbA1c for diabetics, BP, and ECG if required) is obtained from the hospital's internal medicine team. The surgeon performs an informed consent consultation explaining all IOL options, risks, and realistic post-operative expectations. Pupil dilation drops and antibiotic prophylaxis (topical fluoroquinolone, e.g., moxifloxacin 0.5%) are initiated the evening before surgery.
PHASE 3 — SURGERY DAY (Day 2 or 3): Cataract surgery in a modern accredited setting is a day-care procedure. The patient reports to the hospital fasting (if sedation is planned, though most adult cases use topical anaesthesia only). Pre-operative pupil dilation is achieved with tropicamide 1% and phenylephrine 2.5% drops, instilled every 5 minutes over 30–45 minutes. Topical anaesthetic drops are applied. The operating microscope (Zeiss Lumera 700 or Leica M844) is set up with intraoperative aberrometry integration if premium IOL correction is planned. If FLACS is selected, the laser docking step occurs first in the laser suite (10–15 minutes), followed by transfer to the phaco suite. Total surgical time for an uncomplicated phaco procedure is 10–20 minutes. The patient rests in a recovery bay for 30–60 minutes, receives a protective eye shield, and is discharged with a full topical medication kit: topical antibiotic (moxifloxacin 0.5%), topical steroid (prednisolone acetate 1% or dexamethasone 0.1%), and topical NSAID (ketorolac 0.4% or nepafenac 0.1%). Written post-operative instructions are provided in the patient's language.
PHASE 4 — EARLY POST-OPERATIVE PERIOD (Day 1–7 post-surgery): Day 1 post-op: Mandatory slit-lamp review—assessment of wound integrity, anterior chamber depth and clarity, IOL position and centration, and IOP measurement. Most patients report significant visual improvement by Day 1, though some blurring due to residual corneal oedema or posterior capsule wrinkling is normal. Day 3–5: Second review for IOP check and medication compliance assessment; corneal clarity typically fully restored by Day 3–5 in standard phaco cases. Day 7: Third review with refraction and BCVA measurement. In the absence of complications, patients are cleared for short-haul flights (under 4–5 hours) at this visit. Topical steroid is tapered over 4–6 weeks. The topical NSAID is continued for 4–6 weeks to prevent cystoid macular oedema (CMO), particularly in diabetic patients.
PHASE 5 — FIT-TO-FLY ASSESSMENT & DEPARTURE (Day 10–14): For long-haul flights (over 5 hours), the operating surgeon performs a final pre-departure review at Day 10–14. Parameters assessed: IOP stability (target < 21 mmHg), wound integrity (seidel test negative), IOL position, absence of corneal oedema, and absence of early posterior capsule opacification (PCO). A detailed discharge summary, medication list, and instructions for follow-up with the patient's local ophthalmologist are provided. GAF Healthcare coordinates the transfer back to the airport. If bilateral surgery is planned sequentially, the second eye is typically operated on Day 7–10 after the first, extending the total stay.
PHASE 6 — LONG-TERM FOLLOW-UP (1–3 months post-surgery): Posterior capsule opacification (PCO)—the most common long-term complication, occurring in 10–30% of patients within 2–5 years—is managed with a simple outpatient Nd:YAG laser capsulotomy (5 minutes, no anaesthesia required) which can be performed by any ophthalmologist globally. GAF Healthcare coordinates a telemedicine follow-up at 1 month, 3 months, and 1 year post-surgery, ensuring continuity of care across borders.
Risks & Considerations
Cataract surgery is among the safest elective surgical procedures performed globally, with a serious complication rate below 2% in high-volume accredited centres. However, internationally travelling patients should understand the following procedure-specific and journey-specific risks to make fully informed decisions.
Intraoperative risks: Posterior capsule rupture (PCR) is the most significant intraoperative complication, occurring in approximately 0.5–2% of cases even in experienced hands. PCR may necessitate anterior vitrectomy, alteration of IOL placement (sulcus fixation vs. capsular bag), or—in rare cases—deferral of IOL implantation. Zonular dialysis, particularly in patients with pseudoexfoliation syndrome or Marfan syndrome, may require capsular tension ring (CTR) insertion. Suprachoroidal haemorrhage is rare (<0.05%) but sight-threatening. Corneal endothelial damage leading to post-operative bullous keratopathy is a risk in patients with pre-existing low endothelial cell density (ECD < 1,500 cells/mm²).
Top Hospitals for Cataract Surgery
The following JCI and NABH-accredited hospitals are among the most experienced in specialist care, with dedicated teams and high-volume programmes.
All India Institute of Medical Sciences (AIIMS)
New Delhi, India
Christian Medical College (CMC)
Vellore, India
Manipal Hospitals Dwarka
New Delhi, India
Top Doctors for Cataract Surgery
Internationally trained specialists in Ophthalmology. Review their profiles, compare experience, and connect directly through GAF Healthcare.
Dr. Jeewan Singh Titiyal
MBBS, MD (Ophthalmology), FRCOphth (Fellowship), DSc (Honorary Doctor of Science)
Ophthalmologist (Cornea, Cataract & Refractive Surgery)
Dr. Agarwal's Eye Hospital, New Delhi, India
37+ Yearsof experience
Dr. Jeewan Singh Titiyal is one of India's most respected eye surgeons, with a career spanning more than 37 years in cornea, cataract, and refractive surgery. He is a recipient of the Padma Shri (2014), one of India's highest civilian honours, awarded in recognition of his exceptional contributions to ophthalmology. Today he serves as Regional Head of Clinical Services at Dr. Agarwal's Eye Hospital in New Delhi, continuing a lifetime of service to… Read more
Dr. Srilathaa Gunasekaran
MD (Ophthalmology), FAICO (Cornea), FAICO (Refractive Surgery), Cornea Observership
Ophthalmologist — Cornea, Cataract & Refractive Surgery
Fortis Memorial Research Institute, Gurgaon, India
13+ Yearsof experience
Dr. Srilathaa Gunasekaran is a Senior Consultant Ophthalmologist at Fortis Memorial Research Institute, Gurgaon, with over 13 years of experience in cornea, cataract, and refractive surgery. She is one of the few ophthalmologists in the region who performs the full range of corneal transplant procedures — including full-thickness keratoplasty, lamellar surgeries, endothelial keratoplasty, and keratoprosthesis — making her a trusted choice for patients… Read more
Dr. Mainak Bhattacharyya
MS (Ophthalmology), DNB (Diplomate of National Board), FICO (Fellow of the International Council of Ophthalmology), FAICO – Glaucoma (Fellow of the All India Collegium of Ophthalmology)
Ophthalmologist – Glaucoma & Cataract Specialist
Dr Agarwals Eye Hospital, New Delhi, India
10+ Yearsof experience
Dr. Mainak Bhattacharyya is a Senior Consultant Ophthalmologist based in New Delhi, with a focused practice in glaucoma and cataract care spanning more than a decade. He is particularly well regarded for his work in complex glaucoma cases — including refractory glaucoma and paediatric glaucoma — where precise, timely intervention can make the difference between preserved and lost vision. Patients and referring doctors alike trust him for bringing both… Read more
Dr. Rajesh Fogla
MBBS, MS (Ophthalmology), FRCS, FRCOphth, FACS, MMed
Ophthalmologist (Cornea, Cataract & Refractive Surgery)
Apollo Health City, Jubilee Hills, Hyderabad, India
25+ Yearsof experience
Dr. Rajesh Fogla is one of Hyderabad's most respected eye specialists, with over 25 years of dedicated practice in ophthalmology. Based at Apollo Health City in Jubilee Hills, he is particularly known for his expertise in cornea, cataract, and refractive surgery. Patients across India and from abroad seek him out for conditions ranging from routine vision correction to complex surgical challenges that require a steady, experienced hand. Dr. Fogla's… Read more
Dr. Garima Satija
MBBS, MS (Ophthalmology), Cornea Fellowship
Ophthalmologist – Cornea & Cataract Specialist
Fortis Memorial Research Institute, Gurgaon, India
8+ Yearsof experience
Dr. Garima Satija is an ophthalmologist at Fortis Memorial Research Institute, Gurgaon, with a focused practice in cornea, cataract, and anterior segment surgery. Over more than eight years in clinical practice, she has built a reputation for careful surgical technique and a genuinely patient-centered approach — taking the time to explain diagnoses and options in plain language before recommending any procedure. Her training path reflects a deliberate… Read more
Frequently Asked Questions — Cataract Surgery
The cost of cataract surgery depends primarily on three variables: the intraocular lens (IOL) technology chosen, whether femtosecond laser assistance (FLACS) is used, and the accreditation tier of the hospital. In India, the all-inclusive cost per eye ranges from approximately USD 600 for standard phacoemulsification with a monofocal IOL at a NABH/JCI-accredited hospital, up to approximately USD 2,500 for femtosecond laser-assisted surgery (FLACS) with a premium trifocal or EDOF IOL (e.g., Alcon PanOptix, Johnson & Johnson Tecnis Symfony) at a top-tier private eye hospital in cities such as Hyderabad, Chennai, Mumbai, or Delhi. In the UAE (Dubai or Abu Dhabi), the equivalent range is approximately USD 1,500 for standard phaco with a monofocal IOL at a JCI/DHA-accredited facility, rising to approximately USD 5,000 for FLACS with a premium trifocal IOL at a luxury hospital such as Moorfields Eye Hospital Dubai or Cleveland Clinic Abu Dhabi's ophthalmology centre. India is therefore typically 40–60% less expensive than the UAE for the same surgical technique and IOL category. Both destinations include surgeon fees, operating room fees, the IOL itself, nursing care, and immediate post-operative topical medications within these ranges. Pre-operative workup (biometry, Pentacam, specular microscopy) is generally charged separately, ranging from USD 100–300 in India and USD 200–500 in the UAE. GAF Healthcare provides a fully itemised cost estimate for each patient based on their specific biometry report and IOL selection before any travel commitment is made.
For most patients undergoing uncomplicated phacoemulsification cataract surgery on a single eye, the minimum recommended stay before flying is 7 days (1 week). This allows for three mandatory post-operative slit-lamp reviews: Day 1 (wound integrity, IOP, anterior chamber assessment), Day 3–5 (corneal clarity, IOP stability), and Day 7 (refraction, BCVA, final pre-departure surgical assessment). If the Day 7 review confirms a well-healed, self-sealing corneal wound, IOP within the normal range (typically 10–21 mmHg), and no signs of cystoid macular oedema, infection, or IOL decentration, short-haul flights (under 5 hours) are generally approved at this point. For long-haul international flights (over 5 hours), most operating surgeons recommend a minimum stay of 10–14 days to ensure complete wound stability and allow early detection of complications such as elevated IOP or early CMO that may require modification of the post-operative medication regimen before the patient is beyond reach of the surgical team. If both eyes are operated sequentially (typically 7–10 days apart), the total in-country stay will be 14–21 days. Patients with complex cataracts (posterior polar, hypermature, combined phaco-vitrectomy), pre-existing glaucoma, or diabetes may be advised to remain for the full 14-day period regardless of single or bilateral surgery. GAF Healthcare builds this timeline into every travel plan and ensures no patient is cleared for departure without a formal fit-to-fly assessment from the operating surgeon.
Cataract surgery performed using modern phacoemulsification techniques at accredited, high-volume eye centres achieves clinically significant visual improvement in 95–98% of patients. Specifically, in the absence of pre-existing ocular pathology (such as age-related macular degeneration, diabetic maculopathy, glaucomatous optic neuropathy, or amblyopia), the vast majority of patients attain best-corrected visual acuity (BCVA) of 20/40 or better—the legal driving standard in most countries—and approximately 85–90% achieve 20/25 or better. With premium trifocal or EDOF IOLs, 70–80% of patients achieve full spectacle independence (no glasses required for distance, intermediate, and near tasks). The success rate must be contextualised against the patient's specific ocular health: if the retina, optic nerve, or cornea has pre-existing damage, removing the cataract will restore the eye's optical clarity but cannot restore neuronal or photoreceptor function that has already been lost—this is why a thorough pre-operative OCT of the macula and optic nerve, and frank counselling about realistic expectations, is a non-negotiable part of the GAF Healthcare pre-surgical protocol. The rate of serious vision-threatening intraoperative complications (posterior capsule rupture requiring vitrectomy, suprachoroidal haemorrhage, dropped nucleus) is below 2% at the accredited partner hospitals in our network, consistent with published benchmarks from the Royal College of Ophthalmologists (RCOphth) National Ophthalmology Database. Post-operative endophthalmitis—the most feared complication—has an incidence of approximately 0.03–0.05% with intracameral antibiotic prophylaxis, which is standard practice at all GAF Healthcare partner facilities. Long-term, the only common late event is posterior capsule opacification (PCO), affecting 10–30% of patients over 2–5 years, which is definitively and permanently corrected by a single outpatient Nd:YAG laser capsulotomy—a 5-minute, painless procedure available at any well-equipped ophthalmology clinic worldwide.
Why Plan Your Treatment Through Gaf Healthcare?
GAF Healthcare provides a fully integrated, non-medical concierge layer designed to eliminate the logistical friction of international medical travel, allowing patients and their attendants to focus entirely on recovery.
VISA & DOCUMENTATION — INDIA: India's e-Medical Visa (e-MV) is available to nationals of over 170 countries and permits a stay of up to 60 days per visit (extendable), with double-entry permission. GAF Healthcare's visa desk prepares and submits the complete application package—including the official appointment letter from the partner hospital, which is a mandatory attachment—on the patient's behalf. Processing typically takes 3–5 business days. A companion e-Medical Attendant Visa is simultaneously arranged for up to two accompanying family members.
VISA & DOCUMENTATION — UAE: The UAE operates a visa-on-arrival or visa-free regime for passport holders from the GCC, European Union, USA, UK, Canada, Australia, and approximately 50 additional countries, granting 30–90 days of stay. Patients from countries not on this list may require a pre-arranged tourist or medical treatment visa; GAF Healthcare coordinates this through its UAE partner hospitals and local sponsors, with processing in 3–7 business days. The DHA (Dubai Health Authority) Patient Welfare initiative provides additional support for medical visitors to Dubai.
AIRPORT TRANSFERS & IN-COUNTRY TRANSPORT: A dedicated, air-conditioned private vehicle with a GAF Healthcare patient liaison officer meets every patient at arrival—at Indira Gandhi International (DEL), Chhatrapati Shivaji Maharaj (BOM), Kempegowda (BLR), or Rajiv Gandhi (HYD) airports in India, and at Dubai International (DXB) or Abu Dhabi International (AUH) in the UAE. All inter-facility transfers between hotel and hospital are coordinated on the same vehicle throughout the stay.
ACCOMMODATION: GAF Healthcare pre-negotiates preferred rates at hotels within a 5–15 minute drive of the partner hospital, ranging from international business hotels (3-star) to premium luxury options (5-star). For patients who prefer to remain close to the hospital, on-campus patient guest houses or family rooms are arranged at applicable facilities. All accommodation options include provision for the patient's attendant.
CLINICAL TRANSLATORS & PATIENT LIAISONS: For patients whose primary language is not English or the local language, GAF Healthcare provides dedicated medical interpreters who accompany the patient during all clinical consultations, surgical consent discussions, and discharge briefings. Supported languages include Arabic, Russian, French, Swahili, Amharic, Bengali, and others on request.
TELEMEDICINE & POST-DEPARTURE FOLLOW-UP: All patients receive a structured telemedicine follow-up schedule (1 month, 3 months, 12 months) via secure video consultation with their operating surgeon. Medical records, imaging (Pentacam, OCT, biometry reports), and the surgical operative note are shared digitally in a password-protected patient portal accessible from any country, and can be forwarded directly to the patient's local ophthalmologist to ensure seamless continuity of care.
Patients Also Explore
Other treatments commonly sought by patients considering Cataract Surgery.
Rhinoplasty (Nose Job)
Cosmetic Surgery
Liposuction
Cosmetic Surgery
Cochlear Implant
ENT
Hyperthyroidism Treatment
ENT